Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

MASCC Antiemesis Tool (MAT) Screenshots

iPad

iPhone

About MASCC Antiemesis Tool (MAT)

Patients fighting cancer have to deal with Nausea and Vomiting, potential side effects related to chemotherapy. MASCC Antiemesis Tool (MAT) is the first iPhone/iPad application for Cancer patients receiving chemotherapy that helps their doctors in evaluating if and how much the anti-cancer treatment is causing nausea and vomiting.

The MASCC Antiemesis Tool (MAT) is a questionnaire developed and validated by the Multinational Association for Supportive Care in Cancer (MASCC), recognized as the leading Supportive Care Organization in the world. It consists of 4 questions on the intensity and frequency of nausea and/or vomiting after a chemotherapy session, during the first 24 hours and the delayed period (from the day after to 4 days after chemotherapy). By completing the MAT test from their iPhone/iPad devices, patients have the possibility to send the records to their doctors or nurses in real time. In this way the health care professional can promptly follow up and manage the symptom.

The App MAT Tool development was supported by an unrestricted grant from Helsinn Healthcare SA